Latest News
Latest News
84-year-old MD contests employer’s mandatory cognitive tests for older docs
According to the lawsuit, the hospital illegally required neuropsychological and eye examinations of physicians aged 70 or older who sought to...
News
FDA approves second treatment for adults with hidradenitis suppurativa
Secukinumab was previously approved by the FDA for treatment of moderate to severe plaque psoriasis in adults, and several other indications.
News from the FDA/CDC
FDA approves abatacept for pediatric patients with psoriatic arthritis
As many as 5% of pediatric patients with juvenile idiopathic arthritis are estimated to have juvenile PsA.
Latest News
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
Of the 35 trials studied, most involved patients with atopic dermatitis.
Latest News
Phase 3 trial supports topical JAK inhibitor for AD in young children
Already approved in adolescents and adults, topical ruxolitinib was found safe and effective in children.
Latest News
Novel hydrogel holds promise for skin regeneration
The first clinical trials for treating complex diabetic wounds are planned for early 2024.
Latest News
Ready to start engaging on social media? A dermatologist shares tips
Think about your goal. Is it to raise awareness of various dermatologic conditions or to grow your business?
Latest News
Multicenter study aims to find new treatments for hidradenitis suppurativa
The effort includes collection of biospecimens for translational studies to drive drug development.
Latest News
Systematic review spotlights the use of nutraceuticals for acne
Zinc was the most studied nutraceutical, but there was substantial heterogeneity in the results.
From the Journals
Adolescents with atopic dermatitis more likely to have experienced bullying, study finds
“Clinicians, families, and schools should address and monitor bullying among adolescents.”
Conference Coverage
How clinicians can prepare for and defend against social media attacks